1. |
Norton R, Kobusingye O. Injuries. N Engl J Med, 2013, 368(18): 1723-1730.
|
2. |
D'Angelo MR, Dutton RP. Management of trauma-induced coagulopathy: trends and practices. AANA J, 2010, 78(1): 35-40.
|
3. |
Sauaia A, Moore FA, Moore EE, et al. Epidemiology of trauma deaths: a reassessment. J Trauma, 1995, 38(2): 185-193.
|
4. |
Henry DA, Carless PA, Moxey AJ, et al. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev, 2011, (3): CD001886.
|
5. |
Boffard KD, Riou B, Warren B, et al. Recombinant factor Ⅶa as adjunctive therapy for bleeding control in severely injured trauma patients: two parallel randomized, placebo-controlled, double-blind clinical trials. J Trauma, 2005, 59(1): 8-18.
|
6. |
CRASH-2 Trial Collaborators; Shakur H, Roberts I, et al. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH2): a randomised, placebo-controlled trial. Lancet, 2010, 376(9734): 23-32.
|
7. |
Morrison JJ, Dubose JJ, Rasmussen TE, et al. Military application of tranexamic acid in trauma emergency resuscitation (MATTERs) study. Arch Surg, 2012, 147(2): 113-119.
|
8. |
Brohi K, Singh J, Heron M, et al. Acute traumatic coagulopathy. J Trauma, 2003, 54(6): 1127-1130.
|
9. |
Brohi K, Cohen MJ, Ganter MT, et al. Acute coagulopathy of trauma:hypoperfusion induces systemic anticoagulation and hyperfibrino-lysis. J Trauma, 2008, 64(5): 1211-1217.
|
10. |
Brohi K, Cohen MJ, Davenport RA. Acute coagulopathy of trauma: mechanism, identification and effect. Curr Opin Crit Care, 2007, 13(6): 680-685.
|
11. |
Lawson JH, Murphy MP. Challenges for providing effective hemos-tasis in surgery and trauma. Semin Hematol, 2004, 41(1 Suppl 1): 55-64.
|
12. |
Cardenas JC, Wade CE, Holcomb JB. Mechanisms of trauma-induced coagulopathy. Curr Opin Hematol, 2014, 21(5): 404-409.
|
13. |
Cotton BA, Harvin JA, Kostousouv V, et al. Hyperfibrinolysis at admission is an uncommon but highly lethal event associated with shock and prehospital fluid administration. J Trauma Acute Care Surg, 2012, 73(2): 365-370.
|
14. |
Lapostolle F, Sebbah JL, Couvreur J, et al. Risk factors for onset of hypothermia in trauma victims: the HypoTraum study. Crit Care, 2012, 16(4): R142.
|
15. |
Kauvar DS, Wade CE. The epidemiology and modern management of traumatic hemorrhage: US and international perspectives. Crit Care, 2005, 9(Suppl 5): S1-S9.
|
16. |
Okamoto S, Hijikata-Okunomiya A, Wanaka K, et al. Enzyme-controlling medicines: introduction. Semin Thromb Hemost, 1997, 23(6): 493-501.
|
17. |
Panteli M, Papakostidis C, Dahabreh Z, et al. Topical tranexamic acid in total knee replacement: a systematic review and meta-analysis. Knee, 2013, 20(5): 300-309.
|
18. |
McCormack PL. Tranexamic acid: a review of its use in the treatment of hyperfibrinolysis. Drugs, 2012, 72(5): 585-617.
|
19. |
Eubanks JD. Antifibrinolytics in major orthopaedic surgery. J Am Acad Orthop Surg, 2010, 18(3): 132-138.
|
20. |
Ker K, Edwards P, Perel P, et al. Effect of tranexamic acid on surgicalbleeding: systematic review and cumulative meta-analysis. BMJ, 2012, 344: e3054.
|
21. |
Cap AP, Baer DG, Orman JA, et al. Tranexamic acid for trauma patients: a critical review of the literature. J Trauma, 2011, 71(1 Suppl): S9-S14.
|
22. |
CRASH-2 collaborators; Roberts I, Shakur H, et al. The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial. Lancet, 2011, 377(9771): 1096-1101, 1101. e1-e2.
|
23. |
Henry DA, Carless PA, Moxey AJ, et al. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev, 2007, (4): CD001886.
|
24. |
Fiechtner BK, Nuttall GA, Johnson ME, et al. Plasma tranexamic acid concentrations during cardiopulmonary bypass. Anesth Analg, 2001, 92(5): 1131-1136.
|
25. |
Spahn DR, Bouillon B, Cerny V, et al. Management of bleeding and coagulopathy following major trauma: an updated European guideline. Crit Care, 2013, 17(2): R76.
|
26. |
Howes JP, Sharma V, Cohen AT. Tranexamic acid reduces blood loss after knee arthroplasty. Bone Joint Surg Br, 1996, 78(6): 995-996.
|
27. |
Endo Y, Nishimura S, Miura A. Deep-vein thrombosis induced by tranexamic acid in idiopathic thrombocytopenic purpura. JAMA, 1988, 259(24): 3561-3562.
|
28. |
Upadhyay SP, Mallick PN, Jagia M, et al. Acute arterial thrombosis associated with inadvertent high dose of tranexamic acid. Indian J Crit Care Med, 2013, 17(4): 237-239.
|
29. |
Nardi K, Pelone G, Bartolo M, et al. Ischaemic stroke following tranexamic acid in young patients carrying heterozygosity of MTHFR C677T. Ann Clin Biochem, 2011, 48(Pt 6): 575-578.
|
30. |
Kalavrouziotis D, Voisine P, Mohammadi S, et al. High-dose trane-xamic acid is an independent predictor of early seizure after cardiopulmonary bypass. Ann Thorac Surg, 2012, 93(1): 148-154.
|
31. |
Keyl C, Uhl R, Beyersdorf F, et al. High-dose tranexamic acid is related to increased risk of generalized seizures after aortic valve replacement. Eur J Cardiothorac Surg, 2011, 39(5): e114-e121.
|
32. |
Martin K, Knorr J, Breuer T, et al. Seizures after open heart surgery: comparison of ε-aminocaproic acid and tranexamic acid. J Cardiothorac Vasc Anesth, 2011, 25(1): 20-25.
|
33. |
Roberts I, Shakur H, Ker K, et al. Antifibrinolytic drugs for acute traumatic injury. Cochrane Database Syst Rev, 2011, (1): CD004896.
|